246 related articles for article (PubMed ID: 21371587)
1. Key factors for successful generation of protein-fragment structures requirement on protein, crystals, and technology.
Böttcher J; Jestel A; Kiefersauer R; Krapp S; Nagel S; Steinbacher S; Steuber H
Methods Enzymol; 2011; 493():61-89. PubMed ID: 21371587
[TBL] [Abstract][Full Text] [Related]
2. Lead generation and examples opinion regarding how to follow up hits.
Orita M; Ohno K; Warizaya M; Amano Y; Niimi T
Methods Enzymol; 2011; 493():383-419. PubMed ID: 21371599
[TBL] [Abstract][Full Text] [Related]
3. Informatics and modeling challenges in fragment-based drug discovery.
Hubbard RE; Chen I; Davis B
Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855
[TBL] [Abstract][Full Text] [Related]
4. Crystallographic fragment screening.
Badger J
Methods Mol Biol; 2012; 841():161-77. PubMed ID: 22222452
[TBL] [Abstract][Full Text] [Related]
5. Experiences in fragment-based lead discovery.
Hubbard RE; Murray JB
Methods Enzymol; 2011; 493():509-31. PubMed ID: 21371604
[TBL] [Abstract][Full Text] [Related]
6. Combining biophysical screening and X-ray crystallography for fragment-based drug discovery.
Hennig M; Ruf A; Huber W
Top Curr Chem; 2012; 317():115-43. PubMed ID: 21837555
[TBL] [Abstract][Full Text] [Related]
7. Electron density guided fragment-based drug design--a lead generation example.
Abad MC; Gibbs AC; Zhang X
Methods Enzymol; 2011; 493():487-508. PubMed ID: 21371603
[TBL] [Abstract][Full Text] [Related]
8. Medicinal chemistry inspired fragment-based drug discovery.
Lanter J; Zhang X; Sui Z
Methods Enzymol; 2011; 493():421-45. PubMed ID: 21371600
[TBL] [Abstract][Full Text] [Related]
9. High-throughput protein crystallography and drug discovery.
Tickle I; Sharff A; Vinkovic M; Yon J; Jhoti H
Chem Soc Rev; 2004 Oct; 33(8):558-65. PubMed ID: 15480479
[TBL] [Abstract][Full Text] [Related]
10. Advancing fragment binders to lead-like compounds using ligand and protein-based NMR spectroscopy.
Maurer T
Methods Enzymol; 2011; 493():469-85. PubMed ID: 21371602
[TBL] [Abstract][Full Text] [Related]
11. Importance of molecular computer modeling in anticancer drug development.
Geromichalos GD
J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
[TBL] [Abstract][Full Text] [Related]
12. Structural interaction fingerprint (SIFt): a novel method for analyzing three-dimensional protein-ligand binding interactions.
Deng Z; Chuaqui C; Singh J
J Med Chem; 2004 Jan; 47(2):337-44. PubMed ID: 14711306
[TBL] [Abstract][Full Text] [Related]
13. Efficiency of hit generation and structural characterization in fragment-based ligand discovery.
Larsson A; Jansson A; Åberg A; Nordlund P
Curr Opin Chem Biol; 2011 Aug; 15(4):482-8. PubMed ID: 21724447
[TBL] [Abstract][Full Text] [Related]
14. Novel strategy for three-dimensional fragment-based lead discovery.
Yuan H; Lu T; Ran T; Liu H; Lu S; Tai W; Leng Y; Zhang W; Wang J; Chen Y
J Chem Inf Model; 2011 Apr; 51(4):959-74. PubMed ID: 21438547
[TBL] [Abstract][Full Text] [Related]
15. Structure-based drug discovery and protein targets in the CNS.
Hubbard RE
Neuropharmacology; 2011 Jan; 60(1):7-23. PubMed ID: 20673774
[TBL] [Abstract][Full Text] [Related]
16. Computational approach to de novo discovery of fragment binding for novel protein states.
Konteatis ZD; Klon AE; Zou J; Meshkat S
Methods Enzymol; 2011; 493():357-80. PubMed ID: 21371598
[TBL] [Abstract][Full Text] [Related]
17. High-throughput X-ray crystallography for drug discovery.
Blundell TL; Patel S
Curr Opin Pharmacol; 2004 Oct; 4(5):490-6. PubMed ID: 15351354
[TBL] [Abstract][Full Text] [Related]
18. Fragment-based lead discovery using X-ray crystallography.
Hartshorn MJ; Murray CW; Cleasby A; Frederickson M; Tickle IJ; Jhoti H
J Med Chem; 2005 Jan; 48(2):403-13. PubMed ID: 15658854
[TBL] [Abstract][Full Text] [Related]
19. Fragment shuffling: an automated workflow for three-dimensional fragment-based ligand design.
Nisius B; Rester U
J Chem Inf Model; 2009 May; 49(5):1211-22. PubMed ID: 19413347
[TBL] [Abstract][Full Text] [Related]
20. Lead optimization via high-throughput molecular docking.
Joseph-McCarthy D; Baber JC; Feyfant E; Thompson DC; Humblet C
Curr Opin Drug Discov Devel; 2007 May; 10(3):264-74. PubMed ID: 17554852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
